Skip to main content

Table 4 NMBA usage and additional detrimental factors contributing to a lack in postoperative muscle power (t-Test, p-Value)

From: Recovery and prediction of postoperative muscle power – is it still a problem?

Muscle power

NMBA – (n = 268)

NMBA + (n = 347)

T0 h

T0.5 h

T1 h

T2 h

T0 h

T0.5 h

T1 h

T2 h

Gender (M/F)

0.0031

<0.0001

<0.0001

0.0012

<0.0001

<0.0001

<0.0001

<0.0001

Age (≥55)

n.s.

n.s.

0.0433

0.0056

n.s.

n.s.

0.0433

n.s.

BMI (≥30)

n.s.

n.s.

n.s.

n.s.

n.s

n.s.

n.s.

n.s.

TIVA/Balanced Anaesthesia

0.0153

0.0139

<0.0001

0.0014

0.0007

<0.0001

<0.0001

0.0038

Clorazepat (≥20 mg)

0.0210

n.s.

n.s.

n.s.

n.s.

n.s.

n.s.

n.s.

Anaesthesia time(>120 min)

n.s.

0.0389

n.s.

n.s.

0.0446

n.s.

n.s.

0.0231

Fast Track score/PACU(≥10 min.)

n.s.

n.s.

n.s.

n.s.

n.s.

0.0006

<0.0001

0.0046

  1. Abbreviations: NMBA neuromuscular blocking agents, M male, F female, BMI body mass index, TIVA Total intravenous anaesthesia, BIS Bispectral Index, PACU Post anaesthetic care unit